Similar articles

• Plasma lipoprotein metabolism in relation to ischaemic heart disease.

  Rogers MP. Rogers MP. Biochem Soc Trans. 1982 Jun;10(3):159-61. doi: 10.1042/bst0100159. Biochem Soc Trans. 1982. PMID: 7106365 No abstract available.
• High-density lipoproteins: epidemiologic profile and risks of coronary artery disease.

  Kannel WB. Kannel WB. Am J Cardiol. 1983 Aug 22;52(4):9B-12B. doi: 10.1016/0002-9149(83)90649-5. Am J Cardiol. 1983. PMID: 6577783 No abstract available.
• Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.

  Rössner S. Rössner S. J Cardiovasc Pharmacol. 1982;4 Suppl 2:S201-5. J Cardiovasc Pharmacol. 1982. PMID: 6177957 Review. No abstract available.
• Serum lipoproteins and coronary heart disease.

  Berenson GS, Srinivasan SR, Dalferes ER Jr, Puyau FA, O'Meallie LP, Hall RJ, Pargaonkar PS. Berenson GS, et al. Am J Cardiol. 1974 Oct 3;34(5):588-93. doi: 10.1016/0002-9149(74)90132-5. Am J Cardiol. 1974. PMID: 4370368 Review. No abstract available.
• Is the serum total cholesterol an anachronism?

  Kannel WB, Castelli WP. Kannel WB, et al. Lancet. 1979 Nov 3;2(8149):950-1. doi: 10.1016/s0140-6736(79)92638-2. Lancet. 1979. PMID: 91037 No abstract available.